{
  "age": 13,
  "gender": {
    "category": "Male",
    "intersex_condition": null
  },
  "weight": {
    "weight_kg": 43,
    "height_cm": 146,
    "bmi_category": "Healthy"
  },
  "ethnicity": "White European",
  "disease": {
    "name": "Acute myeloid leukaemia of childhood",
    "diagnosed_years_ago": 5,
    "prognosis": "Worsening"
  },
  "comorbidities": [
    {
      "name": "Anaemia",
      "diagnosed_years_ago": 2,
      "prognosis": "Stable"
    },
    {
      "name": "Immunodeficiency",
      "diagnosed_years_ago": 1,
      "prognosis": "Worsening"
    }
  ],
  "treatments": [
    {
      "treatment_name": "Cytarabine",
      "dosage_mg_per_day": 125,
      "percent_week_administered": 100,
      "indication": "Primary"
    },
    {
      "treatment_name": "Idarubicin",
      "dosage_mg_per_day": 12,
      "percent_week_administered": 50,
      "indication": "Primary"
    },
    {
      "treatment_name": "Pegfilgrastim",
      "dosage_mg_per_day": 4,
      "percent_week_administered": 15,
      "indication": "Comorbidity"
    }
  ],
  "genetic_variants": [
    {
      "variant_name": "POR rs2868177",
      "associated_risks": ["Anthracycline cardiotoxicity risk"]
    }
  ]
}
